Table 2

 Patients who withdrew from the study by primary reason

Etanercept 50 mg once weekly (n = 155)Etanercept 25 mg twice weekly (n = 150)Placebo (n = 51)
Values are n (%).
All reasons14 (9.0)14 (9.3)7 (13.7)
Adverse events6 (3.9)8 (5.3)0 (0.0)
Protocol violation5 (3.2)2 (1.3)1 (2.0)
Patient request1 (0.6)1 (0.7)2 (3.9)
Lack of efficacy2 (1.3)3 (2.0)3 (5.9)
Other0 (0)0 (0)1 (2.0)